QSAR STUDY OF HCV NS5B POLYMERASE INHIBITORS USING THE GENETIC ALGORITHM-MULTIPLE LINEAR REGRESSION (GA-MLR)

被引:0
|
作者
Rafiei, Hamid [1 ]
Khanzadeh, Marziyeh [2 ]
Mozaffari, Shahla [2 ]
Bostanifar, Mohammad Hassan [1 ]
Avval, Zhila Mohajeri [2 ]
Aalizadeh, Reza [3 ]
Pourbasheer, Eslam [2 ]
机构
[1] Islamic Azad Univ, Dashtestan Branch, Dept Chem, Dashtestan, Iran
[2] PNU, Dept Chem, POB 19395-3697, Tehran, Iran
[3] Univ Athens, Dept Chem, Analyt Chem Lab, Athens 15771, Greece
来源
EXCLI JOURNAL | 2016年 / 15卷
关键词
QSAR; Genetic algorithms; Multiple linear regression; HCV; HEPATITIS-C; RNA-POLYMERASE; IDENTIFICATION; ANTAGONISTS; PREVENTION; PREDICTION; STRATEGY; THERAPY; INDEXES;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Quantitative structure-activity relationship (QSAR) study has been employed for predicting the inhibitory activities of the Hepatitis C virus (HCV) NS5B polymerase inhibitors. A data set consisted of 72 compounds was selected, and then different types of molecular descriptors were calculated. The whole data set was split into a training set (80 % of the dataset) and a test set (20 % of the dataset) using principle component analysis. The stepwise (SW) and the genetic algorithm (GA) techniques were used as variable selection tools. Multiple linear regression method was then used to linearly correlate the selected descriptors with inhibitory activities. Several validation technique including leave-one-out and leave-group-out cross-validation, Y-randomization method were used to evaluate the internal capability of the derived models. The external prediction ability of the derived models was further analyzed using modified r(2), concordance correlation coefficient values and Golbraikh and Tropsha acceptable model criteria's. Based on the derived results (GA-MLR), some new insights toward molecular structural requirements for obtaining better inhibitory activity were obtained.
引用
收藏
页码:38 / 53
页数:16
相关论文
共 50 条
  • [41] Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking
    Karpinski, Tomasz. M. M.
    Ozarowski, Marcin
    Silva, Pedro. J. J.
    Stasiewicz, Mark
    Alam, Rahat
    Samad, Abdus
    PATHOGENS, 2023, 12 (06):
  • [42] Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors
    Zhou, Longhu
    Amblard, Franck
    Zhang, Hongwang
    McBrayer, Tamara R.
    Detorio, Mervi A.
    Whitaker, Tony
    Coats, Steven J.
    Schinazi, Raymond F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3385 - 3388
  • [43] Synthesis and SAR studies on rhodanine analogs as allosteric inhibitors of HCV NS5B polymerase
    Patel, Bhargav
    Kaushik-Basu, Neerja
    Khadtare, Nikhil
    Kr, Gurukumar
    Basu, Amartya
    Arora, Payal
    Talele, Tanaji T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [44] QSAR Study of Malonyl-CoA Decarboxylase Inhibitors Using GA-MLR and a New Strategy of Consensus Modeling
    Li, Jiazhong
    Lei, Reilei
    Liu, Huanxiang
    Li, Shuyan
    Yao, Xiaojun
    Liu, Mancang
    Gramatica, Paola
    JOURNAL OF COMPUTATIONAL CHEMISTRY, 2008, 29 (16) : 2636 - 2647
  • [45] Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors
    Hendricks, Robert T.
    Fell, Jay B.
    Blake, James F.
    Fischer, John P.
    Robinson, John E.
    Spencer, Stacey R.
    Stengel, Peter J.
    Bernacki, April L.
    Leveque, Vincent J. P.
    Le Pogam, Sophie
    Rajyaguru, Sonal
    Najera, Isabel
    Josey, John A.
    Harris, Jason R.
    Swallow, Steven
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3637 - 3641
  • [46] QSAR modeling of antimalarial activity of urea derivatives using genetic algorithm-multiple linear regressions
    Beheshti, Abolghasem
    Pourbasheer, Eslam
    Nekoei, Mehdi
    Vahdani, Saadat
    JOURNAL OF SAUDI CHEMICAL SOCIETY, 2016, 20 (03) : 282 - 290
  • [47] Development of novel non-nucleoside HCV NS5B polymerase inhibitors: QSAR, molecular docking directed synthesis and in vitro studies
    Patil, Vaishali
    Masand, Neeraj
    Gupta, Satya Prakash
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [48] Optimization of N-alkyl indole allosteric inhibitors of the HCV NS5B polymerase enzyme
    Pacini, Barbara
    Altamura, Sergio
    Avolio, Salvatore
    Bisbocci, Monica
    DiFilippo, Marcello
    DiMarco, Stefania
    Paz, Odalys Gonzalez
    Laufer, Ralph
    Narjes, Frank
    Paonessa, Giacomo
    Rowley, Michael
    Harper, Steven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 669 - 669
  • [49] Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase
    Harikishore, Amaravadhi
    Li, Enlin
    Lee, Jia Jun
    Cho, Nam-Joon
    Yoon, Ho Sup
    MOLECULAR DIVERSITY, 2015, 19 (03) : 529 - 539
  • [50] Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors
    Das, Debasis
    Hong, Jian
    Chen, Shu-Hui
    Wang, Guangyi
    Beigelman, Leonid
    Seiwert, Scott D.
    Buckman, Brad O.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (16) : 4690 - 4703